SHH · 603259.SS
WuXi AppTec Co., Ltd.
CN¥142.01-CN¥0.88 (-0.62%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.2% below the high.
Loading market information…
SHZ · 002223.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.03% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.’s forward annual dividend is CN¥1.60 per share, paid quarterly. The forward yield is 5.76% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.’s next earnings report is currently expected on Apr 26, 2027, with estimated earnings per share of CN¥0.12. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd., formerly known as Yuwell Medical, was established in 1998 and is headquartered in Shanghai, China. The company operates globally, manufacturing and distributing a diverse array of medical devices in both domestic and international markets. Its extensive product catalog includes sophisticated respiratory therapy solutions, such as ventilators, humidifiers, oxygen generators, nebulizers, and advanced non-invasive ventilator data management systems. Yuwell also offers comprehensive chronic disease monitoring systems, featuring sphygmomanometers, blood glucose meters, pulse oximeters, thermometers, stethoscopes, alongside general practice diagnostic tools and in-hospital blood glucose management platforms. Furthermore, the company provides cutting-edge imaging diagnosis and treatment solutions, including ultrasound diagnostic imaging, interventional, and minimally invasive technologies. Its offerings extend to infection control and disinfection products, as well as specialized ophthalmology and vision care items like microscopes, eye surgical instruments, ophthalmoscopes, synoptophores, and keratometers. Defibrillator monitors are also part of their product range. Additionally, Yuwell supplies a broad spectrum of durable medical equipment and consumables, encompassing basic and microsurgical tools, instruments for ENT and orthopedics, endoscopic devices, dental appliances, acupuncture and electronic acupuncture products, absorbable sutures, and venous indwelling needles.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:38 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥1.89B |
| Q2 2025 | Aug 22, 2025 | CN¥0.58 | CN¥2.22B |
|---|
| Q1 2025 | Apr 26, 2025 | CN¥0.63+0.8% vs estimate | CN¥2.44B-0.01% vs estimate |
|---|
| Q1 2025 | Apr 26, 2025 | CN¥0.27-10.0% vs estimate | CN¥1.54B0.0% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥142.01-CN¥0.88 (-0.62%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.2% below the high.
CN¥48.46-CN¥0.16 (-0.33%)
Jiangsu Hengrui Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.39% below the high.
CN¥181.75+CN¥2.75 (+1.54%)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 19.04% below the high.
CN¥56.24+CN¥5.11 (+9.99%)
Andon Health Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.76% below the high.
CN¥18.01-CN¥0.12 (-0.66%)
Sinocare Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.37% below the high.
CN¥11.84+CN¥0.10 (+0.85%)
Edan Instruments, Inc.’s quoted price sits in the lower half of its reported 52-week range, 29.52% below the high.
CN¥9.77-CN¥0.27 (-2.69%)
Contec Medical Systems Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 46.02% below the high.
CN¥12.02-CN¥0.25 (-2.04%)
Guangdong Biolight Meditech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 45.31% below the high.
